Incidence of cancers and autoimmune diseases in myasthenia gravis (MG) patients with and without thymectomy

Key Points

• Incidence of cancers and autoimmune diseases differs significantly between myasthenia gravis patients depending on thymectomy status, highlighting its impact.
• Increased autoimmune disease incidence was observed in MG patients without thymectomy, indicating a possible correlation to cancer risk.
• Observational analysis focusing on MG patients revealed insights into the relationship between thymectomy and disease incidence.
• Understanding these differences may enable targeted management strategies for myasthenia gravis patients with distinct cancer and autoimmune disease risks.